Annals of Diagnostic Pathology
Volume 11, Issue 6 , Pages 453-456 , December 2007

Urinary bladder adenocarcinoma arising in a spina bifida patient

  • Mireille Bitar, MD

      Affiliations

    • Department of Pathology, The Mount Sinai School Of Medicine, New York, NY 10029, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 917 9417286 (Mobile); fax: +1 212 289 2899.
    • ,
  • Edmund Mandel, MD

      Affiliations

    • Department of Urology, The Mount Sinai School Of Medicine, New York, NY 10029, USA
    • ,
  • Alexander M. Kirschenbaum, MD

      Affiliations

    • Department of Urology, The Mount Sinai School Of Medicine, New York, NY 10029, USA
    • ,
  • Pamela D. Unger, MD

      Affiliations

    • Department of Pathology, The Mount Sinai School Of Medicine, New York, NY 10029, USA

References 

  1. Edwards PD, Hurm RA, Jaeschke WH. Conversion of cystitis glandularis to adenocarcinoma. J Urol. 1972;108:568–570
  2. Susmano D, Rubenstein AB, Dakin AR, Lioyd FA. Cystitis glandularis and adenocarcinoma of the bladder. J Urol. 1971;105:671–674
  3. Bullock PS, Thoni DE, Murphy WM. The significance of colonic mucosa (intestinal metaplasia) involving the urinary tract. Cancer. 1987;59:2086–2090
  4. Emmett JL, McDonald JR. Proliferation of glands of the urinary bladder simulating malignant neoplasm. J Urol. 1942;48:257
  5. Reuter VE, Melamed MR. The urothelial tract. In:  Sternberg SS editors. Diagnostic surgical pathology. 3rd ed.. Philadelphia: Lippincott Williams and Wilkins; 1999;p. 1853–1891
  6. Murphy WM, Beckwith JB, Farrow GM. Tumors of the urinary bladder. In:  Rosi J editors. Tumor of the kidney, bladder, and related urinary structures. Washington (DC): Armed Forces Institute of Pathology AFIP; 1994;p. 193–297
  7. Pantuck AJ, Bancila E, Das KM, et al. Adenocarcinoma of the urachus and bladder expresses a unique colonic epithelial epitope: an immunohistochemical study. J Urol. 1997;158:1722–1727
  8. Curtis MW, Evans AJ, Srigley JR. Mucin-producing urothelial-type adenocarcinoma of prostate: report of two cases of a rare and diagnostically challenging entity. Mod Pathol. 2005;18:585–590
  9. Wang HL, et al. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Am J Surg Pathol. 2001;11:1380–1387
  10. Werling RW, Yaziji H, Bacchi CE, Gown AM. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol. 2003;27:303–310
  11. Stonehill WH, Dmochowski RR, Patterson AL, Cox CE. Risk factors for bladder tumors in spinal cord injury patients. J Urol. 1996;155:1248–1250
  12. Djavan D, Litwiller SE, Milghgrub S, Roehrborn CG. Mucinous adenocarcinoma in defunctionalized bladders. Urology. 1995;46:107–110
  13. Game X, Villers A, Malavaud B, Sarramon JP. Bladder cancer arising in a spina bifida patient. Urology. 1999;54(5):923

PII: S1092-9134(06)00074-8

doi: 10.1016/j.anndiagpath.2006.06.002

Annals of Diagnostic Pathology
Volume 11, Issue 6 , Pages 453-456 , December 2007

Article Tools

* Image Usage & Resolution